The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a further analysis, the latter authors found a 31% decreased risk for subjects without a history of liver disease (RR = 0.69; 95% CI = 0.43–0.58) and 44% for persons with a history of liver disease (RR = 0.56; 95% CI = 0.35–0.91) [185].”
From Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update (2022) · cites this paper as [185]
In the citing paper
“In a further analysis, the latter authors found a 31% decreased risk for subjects without a history of liver disease (RR = 0.69; 95% CI = 0.43–0.58) and 44% for persons with a history of liver disease (RR = 0.56; 95% CI = 0.35–0.91) [185].”
From Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update (2022) · cites this paper as [185]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Coffee Consumption and Risk of Type 2 Diabetes: A Systematic Review
van Dam, R. M., & Hu, F. B. (2005) · JAMA · doi:10.1001/jama.294.1.97 · Cited by 662
Research works printed but not linked: 37
- Nilssen, 1990, The Tromso Study, Am J Epidemiol, 132, 318, 10.1093/oxfordjournals.aje.a115661 · DOI · Paper page
- Casiglia, 1993, Unexpected effects of coffee consumption on liver enzymes, Eur J Epidemiol, 9, 293, 10.1007/BF00146266 · DOI
- Kono, 1994, Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan, Am J Epidemiol, 139, 723, 10.1093/oxfordjournals.aje.a117062 · DOI
- Pintus, 1996, Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants, Eur J Epidemiol, 12, 71, 10.1007/BF00144431 · DOI
- Poikolainen, 1997, Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee, Am J Epidemiol, 146, 1019, 10.1093/oxfordjournals.aje.a009230 · DOI
- Tanaka, 1998, Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers, Int J Epidemiol, 27, 438, 10.1093/ije/27.3.438 · DOI
- Honjo, 1999, Coffee drinking and serum gamma-glutamyltransferase: an extended study of Self-Defense Officials of Japan, Ann Epidemiol, 9, 325, 10.1016/S1047-2797(99)00013-7 · DOI
- Nakanishi, 2000, Coffee consumption and decreased serum gamma-glutamyltransferase: a study of middle-aged Japanese men, Eur J Epidemiol, 16, 419, 10.1023/A:1007683626665 · DOI
- Nakanishi, 2000, Effects of coffee consumption against the development of liver dysfunction: a 4-year follow-up study of middle-aged Japanese male office workers, Ind Health, 38, 99, 10.2486/indhealth.38.99 · DOI
- Honjo, 2001, Coffee consumption and serum aminotransferases in middle-aged Japanese men, J Clin Epidemiol, 54, 823, 10.1016/S0895-4356(01)00344-4 · DOI
- Ruhl, 2005, Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States, Gastroenterology, 129, 1928, 10.1053/j.gastro.2005.08.056 · DOI
- Corrao, 2001, Coffee, caffeine, and the risk of liver cirrhosis, Ann Epidemiol, 11, 458, 10.1016/S1047-2797(01)00223-X · DOI
- Corrao, 1994, The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption, Eur J Epidemiol, 10, 657, 10.1007/BF01719277 · DOI
- Gallus, 2002, Does coffee protect against liver cirrhosis?, Ann Epidemiol, 12, 202, 10.1016/S1047-2797(01)00304-0 · DOI
- Klatsky, 1992, Alcohol, smoking, coffee, and cirrhosis, Am J Epidemiol, 136, 1248, 10.1093/oxfordjournals.aje.a116433 · DOI · Paper page
- Tverdal, 2003, Coffee intake and mortality from liver cirrhosis, Ann Epidemiol, 13, 419, 10.1016/S1047-2797(02)00462-3 · DOI
- Tanaka, 1990, Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters, Basic Life Sci, 52, 429
- La Vecchia, 1989, Coffee consumption and digestive tract cancers, Cancer Res, 49, 1049
- Kuper, 2000, Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma, Int J Cancer, 85, 498, 10.1002/(SICI)1097-0215(20000215)85:4<498::AID-IJC9>3.0.CO;2-F · DOI
- Kurozawa, 2004, Dietary habits and risk of death due to hepatocellular carcinoma in a large scale cohort study in Japan, Kurume Med J, 51, 141, 10.2739/kurumemedj.51.141 · DOI
- Inoue, 2005, Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan, J Natl Cancer Inst, 97, 293, 10.1093/jnci/dji040 · DOI
- Shimazu, 2005, Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan, Int J Cancer, 116, 150, 10.1002/ijc.20989 · DOI
- Kurozawa, 2005, Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan, Br J Cancer, 93, 607, 10.1038/sj.bjc.6602737 · DOI
- Gallus, 2002, Does coffee protect against hepatocellular carcinoma?, Br J Cancer, 87, 956, 10.1038/sj.bjc.6600582 · DOI
- Gelatti, 2005, Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case–control study, J Hepatol, 42, 528, 10.1016/j.jhep.2004.11.039 · DOI
- Ohfuji, 2006, Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: A case–control study, Hepatol Res, 36, 201, 10.1016/j.hepres.2006.07.010 · DOI
- Tanaka, 2007, Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case–control study in Japan, Cancer Sci, 98, 214, 10.1111/j.1349-7006.2006.00368.x · DOI
- Orsini, 2006, Generalized least squares for trend estimation of summarized dose–response data, Stata J, 6, 40, 10.1177/1536867X0600600103 · DOI · Paper page
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Hasegawa, 1989, Fasting plasma caffeine level in cirrhotic patients: relation to plasma levels of catecholamines and renin activity, Hepatology, 10, 973, 10.1002/hep.1840100614 · DOI
- Wahllander, 1985, Fasting plasma caffeine concentration, Scand J Gastroenterol, 20, 1133, 10.3109/00365528509088884 · DOI
- Ruhl, 2005, Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States, Gastroenterology, 128, 24, 10.1053/j.gastro.2004.09.075 · DOI · Paper page
- He, 2001, Suppressive effect of coffee on lipopolysaccharide-induced hepatitis in D-galactosamine-sensitized rats, Biosci Biotechnol Biochem, 65, 1924, 10.1271/bbb.65.1924 · DOI
- La Vecchia, 1998, Liver cirrhosis and the risk of primary liver cancer, Eur J Cancer Prev, 7, 315, 10.1097/00008469-199808000-00007 · DOI
- El-Serag, 2006, The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence, Clin Gastroenterol Hepatol, 4, 369, 10.1016/j.cgh.2005.12.007 · DOI
Cited by
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Coffee: Biochemistry and Potential Impact on Health
Ludwig, I. A., Clifford, M. N., Lean, M. E. J., Ashihara, H., & Crozier, A. (2014) · Food Funct. · doi:10.1039/c4fo00042k · Cited by 537
Coffee, Caffeine, and Health Outcomes: An Umbrella Review
Grosso, G., Godos, J., Galvano, F., & Giovannucci, E. L. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064941 · Cited by 531
Farah, A. (2012) · Coffee · doi:10.1002/9781119949893.ch2 · Cited by 330
High-Temperature Beverages and Foods and Esophageal Cancer Risk—A Systematic Review
Islami, F., Boffetta, P., Ren, J., Pedoeim, L., Khatib, D., & Kamangar, F. (2009) · International Journal of Cancer · doi:10.1002/ijc.24445 · Cited by 322
Caffeine’s Vascular Mechanisms of Action
Echeverri, D., Montes, F. R., Cabrera, M., Galán, A., & Prieto, A. (2010) · International Journal of Vascular Medicine · doi:10.1155/2010/834060 · Cited by 233
Effects of Coffee on the Gastro-Intestinal Tract: A Narrative Review and Literature Update
Nehlig, A. (2022) · Nutrients · doi:10.3390/nu14020399 · Cited by 158
Kalthoff, S., Ehmer, U., Freiberg, N., Manns, M. P., & Strassburg, C. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.048 · Cited by 124
Coffee Phenolic Phytochemicals Suppress Colon Cancer Metastasis by Targeting MEK and TOPK
Kang, N. J., Lee, K. W., Kim, B. H., Bode, A. M., Lee, H.-J., Heo, Y.-S., Boardman, L., Limburg, P., Lee, H. J., & Dong, Z. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr022 · Cited by 123
Nakayama, T., & Oishi, K. (2013) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12142 · Cited by 97
Murad, L. D., Soares, N. D. C. P., Brand, C., Monteiro, M. C., & Teodoro, A. J. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1004736 · Cited by 89
Bhurwal, A., Ratta, P., Yoshitake, S., Pioppo, L., Reja, D., Dellatore, P., & Rustgi, V. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-805 · Cited by 61
Choi, D. W., Lim, M. S., Lee, J. W., Chun, W., Lee, S. H., Nam, Y. H., Park, J. M., Choi, D. H., Kang, C. D., Lee, S. J., et al. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.133 · Cited by 53
(2015) · PubMed · Cited by 35
Oleaga, C., Ciudad, C. J., Noé, V., & Izquierdo-Pulido, M. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/390385 · Cited by 25
“Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2012, Article ID 390385, 17 pages doi:10.1155/2012/390385”
BackgroundInfluential
Metadata
- Authors
- Larsson, S. C., & Wolk, A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 132
- Issue
- 5
- Pages
- 1740-1745
- ISSN
- 0016-5085
- Cited by
- 218
- References
- 2
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.